利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

16 条记录 (耗时 0.026 秒)

    Bridged polycyclic compound based compositions for coating oral surfaces in humans
    2.
    发明授权
    Bridged polycyclic compound based compositions for coating oral surfaces in humans 有权
    用于在人体中涂覆口腔表面的桥接多环化合物基组合物

    公开(公告)号：US08153617B2

    公开(公告)日：2012-04-10

    申请号：US12228263

    申请日：2008-08-11

    申请人： Jeffery A. Whiteford

    发明人： Jeffery A. Whiteford

    IPC分类号： A61K31/33

    CPC分类号： A61K31/395 ,  A61K8/416 ,  A61K8/42 ,  A61K8/43 ,  A61K31/4162 ,  A61K31/4353 ,  A61Q11/00

    摘要： A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, one or more bridged polycyclic compounds may be applied to an oral surface of a human such that an oral malady may be inhibited and/or ameliorated.

    摘要翻译： 描述了药物活性剂，药物活性剂载体及其使用方法。 在一些实施方案中，系统可以包括组合物。 组合物可以包括一种或多种桥连多环化合物。 桥连多环化合物中的至少一种可以包括至少两个环状基团，并且至少两种药学活性剂可以与桥连多环化合物缔合。 在一些实施方案中，可以将一种或多种桥连多环化合物施用于人的口腔表面，使得可以抑制和/或改善口腔疾病。

    BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE
    7.
    发明申请
    BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE 审中-公开
    用于抑制和改善疾病的基于多环化合物的组合物

    公开(公告)号：US20130040924A1

    公开(公告)日：2013-02-14

    申请号：US13548975

    申请日：2012-07-13

    申请人： Jeffery A. Whiteford

    发明人： Jeffery A. Whiteford

    IPC分类号： A61K31/395 ,  A61P35/00 ,  A61P31/12 ,  A61P31/10 ,  C07D487/08 ,  A61P31/04

    CPC分类号： B82Y5/00 ,  A61K47/547 ,  A61K47/6949

    摘要： A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, a bridged polycyclic compound may be pharmaceutically active. In some embodiments, a bridged polycyclic compound may be function as a carrier for pharmaceutically active agents.

    摘要翻译： 描述了药物活性剂，药物活性剂载体及其使用方法。 在一些实施方案中，系统可以包括组合物。 组合物可以包括一种或多种桥连多环化合物。 桥连多环化合物中的至少一种可以包括至少两个环状基团，并且至少两种药学活性剂可以与桥连多环化合物缔合。 在一些实施方案中，桥连多环化合物可以是药学活性的。 在一些实施方案中，桥连多环化合物可以用作药物活性剂的载体。

    Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
    8.
    发明授权
    Bridged polycyclic compound based compositions for the inhibition and amelioration of disease 有权
    用于抑制和改善疾病的桥联多环化合物基组合物

    公开(公告)号：US08222239B2

    公开(公告)日：2012-07-17

    申请号：US12035351

    申请日：2008-02-21

    申请人： Jeffery A. Whiteford

    发明人： Jeffery A. Whiteford

    IPC分类号： A61K31/33 ,  C07D245/00

    CPC分类号： B82Y5/00 ,  A61K47/547 ,  A61K47/6949

    摘要： A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, a bridged polycyclic compound may be pharmaceutically active. In some embodiments, a bridged polycyclic compound may be function as a carrier for pharmaceutically active agents.

    摘要翻译： 描述了药物活性剂，药物活性剂载体及其使用方法。 在一些实施方案中，系统可以包括组合物。 组合物可以包括一种或多种桥连多环化合物。 桥连多环化合物中的至少一个可以包括至少两个环状基团，并且至少两种药物活性剂可以与桥连多环化合物缔合。 在一些实施方案中，桥连多环化合物可以是药学活性的。 在一些实施方案中，桥连多环化合物可以用作药物活性剂的载体。

    Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
    10.
    发明授权
    Bridged polycyclic compound based compositions for the inhibition and amelioration of disease 有权

    公开(公告)号：US09994444B2

    公开(公告)日：2018-06-12

    申请号：US13548975

    申请日：2012-07-13

    申请人： Jeffery A. Whiteford

    发明人： Jeffery A. Whiteford

    IPC分类号： B82Y5/00 ,  A61K47/54 ,  A61K47/69

    CPC分类号： B82Y5/00 ,  A61K47/547 ,  A61K47/6949

    摘要： A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, a bridged polycyclic compound may be pharmaceutically active. In some embodiments, a bridged polycyclic compound may be function as a carrier for pharmaceutically active agents.